The dental bone graft substitutes market is projected to reach USD 2.04 billion by 2031 from USD 1.40 billion in 2026, at a CAGR of 6.5% during the forecast period.
The dental bone graft substitutes industry is largely driven by a rising prevalence of dental diseases, such as tooth loss, periodontitis, and maxillofacial defects. This surge has increased the demand for effective bone regeneration solutions. Additionally, the growing popularity of dental implants and advanced restorative materials has significantly increased demand for high-quality graft materials.
Innovations in graft substitutes, such as xenografts, allografts, and synthetic alternatives, have led to better clinical outcomes, greater predictability, and greater convenience, making them the preferred choice among dental practitioners. Furthermore, the growing awareness of oral health among patients and clinicians, along with the expansion of dental facilities and specialized surgical services, has positively impacted market growth.
As a result, socket preservation is a viable option within the dental bone graft substitutes market. Dental bone graft substitutes are typically placed immediately after an extraction to stabilize the socket and promote bone formation. Tooth extractions are quite common worldwide for various reasons, including dental caries, periodontal disease, and trauma, underscoring the importance of the socket preservation market. This segment is widely appreciated in the industry for its ease of application and predictable outcomes, making it a favored choice among dentists across specialties.
These cases include dental implant procedures, periodontal treatments, and jaw rebuilding or reconstruction surgeries. Bone graft substitutes are essential for all dental and jaw surgeries, given the high technical and clinical demands of these procedures. Additionally, dental and jaw departments in hospitals are well-established and efficiently managed, thereby enhancing their capacity to use these substitutes effectively. Consequently, hospitals are considered the primary end-user facilities for dental bone substitutes.
The dental bone graft substitutes industry is largely driven by a rising prevalence of dental diseases, such as tooth loss, periodontitis, and maxillofacial defects. This surge has increased the demand for effective bone regeneration solutions. Additionally, the growing popularity of dental implants and advanced restorative materials has significantly increased demand for high-quality graft materials.
Innovations in graft substitutes, such as xenografts, allografts, and synthetic alternatives, have led to better clinical outcomes, greater predictability, and greater convenience, making them the preferred choice among dental practitioners. Furthermore, the growing awareness of oral health among patients and clinicians, along with the expansion of dental facilities and specialized surgical services, has positively impacted market growth.
The combination of clinical needs, technological advancements, and heightened patient awareness is driving the global demand for dental bone graft substitutes.
By application, resins are expected to hold the largest market share in the dental bone graft substitutes market.
In the dental bone graft substitutes market, the socket preservation segment holds the largest share. This is due to its frequent use during the postoperative period following tooth extractions and its crucial role in preserving alveolar bone stock. After a tooth extraction, rapid bone resorption may eventually necessitate the placement of dental implants.As a result, socket preservation is a viable option within the dental bone graft substitutes market. Dental bone graft substitutes are typically placed immediately after an extraction to stabilize the socket and promote bone formation. Tooth extractions are quite common worldwide for various reasons, including dental caries, periodontal disease, and trauma, underscoring the importance of the socket preservation market. This segment is widely appreciated in the industry for its ease of application and predictable outcomes, making it a favored choice among dentists across specialties.
By end user, hospitals are expected to hold the largest share in the dental bone graft substitutes market.
In the dental bone graft substitutes market, hospitals hold a significant market share. This is largely due to their established clinical settings and ability to treat a large number of patients while performing various complex dental and oral surgeries. For example, hospitals are equipped to handle cases requiring dental and jaw reconstruction procedures that involve bone grafting substitutes.These cases include dental implant procedures, periodontal treatments, and jaw rebuilding or reconstruction surgeries. Bone graft substitutes are essential for all dental and jaw surgeries, given the high technical and clinical demands of these procedures. Additionally, dental and jaw departments in hospitals are well-established and efficiently managed, thereby enhancing their capacity to use these substitutes effectively. Consequently, hospitals are considered the primary end-user facilities for dental bone substitutes.
The US is expected to grow at the highest CAGR in the North American dental bone graft substitutes market during the forecast period.
The dental bone graft substitutes market in North America is expected to grow at the highest rate in the US, driven by several key factors. A growing aging population and an increasing prevalence of age-related dental issues, such as tooth loss and periodontitis, are driving the demand for dental substitutes in the country. Additionally, the presence of a favorable dental care infrastructure and a greater acceptance of innovative dental technologies are contributing to the growth of dental bone graft substitutes in America. Furthermore, the rising use of dental procedures like dental implantology, along with increasing awareness of dental and periodontal health among dental surgeons and conscientious consumers, is also supporting the expansion of this market. Collectively, these factors have positioned the US as the leading market for dental bone graft substitutes in North America.A breakdown of the primary participants (on the supply side) for the dental bone graft substitutes market referenced in this report is provided below:
- By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
- By Designation: C-level Executives (45%), Directors (35%), and Others (20%)
- By Region: North America (27%), Europe (25%), Asia Pacific (30%), Latin America (8%), and the Middle East & Africa (10%)
Research Coverage:
The report provides an analysis of the dental bone graft substitutes market, focusing on estimating its size and future growth potential across segments such as product, application, type, mechanism, end user, and region. Additionally, the report features a competitive analysis of key players in the market, including their company profiles, product offerings, recent developments, and key market strategies.Reasons to Buy the Report
The report provides valuable insights for both market leaders and new entrants in the dental bone graft substitutes market, offering the most accurate revenue estimates. It helps stakeholders understand the competitive landscape, enabling them to better position their businesses and develop effective go-to-market strategies. Additionally, the report highlights key market drivers, restraints, challenges, and opportunities, giving stakeholders a comprehensive understanding of current market trends.This report provides insights into the following pointers:
- Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and subsequent increase in tooth repair procedures, and changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, and dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising DSO activity, and growing demand for bone graft substitutes from emerging markets), and challenges (pricing pressure faced by prominent market players).
- Market Penetration: It includes extensive information on the products offered by the major players in the global dental bone graft substitutes market. The report includes various segments, such as products, applications, types, mechanisms, end users, and regions.
- Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitutes market.
- Market Development: Thorough knowledge and analysis of the profitable rising markets by product, type, mechanism, application, end user, and region.
- Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global dental bone graft substitutes market.
- Competitive Assessment: A comprehensive assessment of market shares, growth strategies, product offerings, and capabilities of key competitors in the global dental bone graft substitutes market.
Table of Contents
1 INTRODUCTION
2 EXECUTIVE SUMMARY
3 PREMIUM INSIGHTS
4 MARKET OVERVIEW
5 INDUSTRY TRENDS
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
7 REGULATORY LANDSCAPE
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
9 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE
10 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION
11 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM
12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER
13 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION
14 COMPETITIVE LANDSCAPE
15 COMPANY PROFILES
16 RESEARCH METHODOLOGY
17 APPENDIX
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- DENTSPLY SIRONA INC.
- ENVISTA
- INSTITUT STRAUMANN AG
- ADVANCED MEDICAL SOLUTIONS GROUP PLC
- ZIMVIE INC.
- HENRY SCHEIN, INC.
- EVERGEN (FORMERLY RTI SURGICAL)
- LIFENET HEALTH
- NOVABONE
- GEISTLICH PHARMA AG
- BOTISS BIOMATERIALS GMBH
- REGENITY
- OSTEOGENIC BIOMEDICAL
- HANNOX INTERNATIONAL CORP
- KEYSTONE DENTAL GROUP
- YOUNG INNOVATIONS INC
- BEGO GMBH &CO.KG
- TISSUE REGENIX GROUP
- DENTIUM CO., LTD
- MEDBONE
- PURGO BIOLOGICS INC
- REGEDENT AG
- TECNOSS DENTAL SRL
- SIGMAGRAFT BIOMATERIALS
- CITAGENIX
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 268 |
| Published | February 2026 |
| Forecast Period | 2026 - 2031 |
| Estimated Market Value ( USD | $ 1.4 Billion |
| Forecasted Market Value ( USD | $ 2.04 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 25 |
